Ignite Creation Date:
2024-07-17 @ 10:55 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06484153
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-05-24
Brief Title:
Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Advanced or Metastatic pMMRMSS Colorectal Carcinoma
Sponsor:
Wuhan Union Hospital China
Organization:
Wuhan Union Hospital China
Organization Data
Organization:
Wuhan Union Hospital China
Class:
OTHER
Study ID:
union-P
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Wuhan Union Hospital China
Lead Sponsor Class:
OTHER
Responsible Party:
Tao Zhang
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Wuhan Union Hospital China
Old Name:
None
Old Organization:
None